Skip to content

Bewegingstherapie via het internet voor patienten met type 2 diabetes.

Interactive exercise therapy at home: A web based solution to improve long-term adherence, self-management and clinical efficacy of a life-style intervention program for patients with type 2 diabetes.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23270
Enrollment
48
Registered
2010-02-25
Start date
2010-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type 2

Interventions

Patients will be randomized to follow either a supervised progressive interval endurance and resistance type of training at the ErasmusMC (13 weeks) combined with an interactive web based (LiveWorkout

Sponsors

Erasmus Medical Center Department of Rehabilitation Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes <15 years; 2. HbA1c: 7.0- 10.0%; 3. Age: 35-75 yrs; 4. BMI: 27-40 kg/m2; 5. Access to broadband internet including a personal computer with USB-interface.

Exclusion criteria

Exclusion criteria: 1. Cardio-vascular disease; 2. Severe orthopaedic impairments; 3. Renal failure or >grade III retinopathy or previous diabetic foot ulcer; 4. Cerebro-vascular disease (CVA), neurological diseases or deficits.

Design outcomes

Primary

MeasureTime frame
Adherence to the exercise program as measured by percentage of dropouts as well as an increase in total weekly energy expenditure. The feasibility of the LiveWorkout and Direct Live program.

Secondary

MeasureTime frame
1. Movement-related everyday activity/energy expenditure and functional capacity Muscle strength and resistance to fatigue; 2. Glycemic control (HbA1c) and fasting plasma glucose; 3. Cardiovascular risk profile.

Contacts

Public ContactD. Visser

P.O. box 2040

d.visser.1@erasmusmc.nl+31 (0)10 7031679

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)